Tamtuvetmab (AT-005) is a caninised blontuvetmab against CD52. Tamtuvetmab increases progression-free survival (PFS), exhibits in vivo efficacy in dogs with naive T-cell lymphoma (LSA). Tamtuvetmab has been approved by veterinary[1][2].
Molecular Weight:
(146.346 kDa)
Purity:
97
CAS Number:
[1608122-71-9]
Target:
NF-kappaB
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
